| Identification | Back Directory | [Name]
Cabozantinib impurity 1DYH | [CAS]
1621681-63-7 | [Synonyms]
Cabozantinib impurity 1DYH
4-(4-(1-((4-fluorophenyl)carbamoyl)cyclopropane-1-carboxamido)phenoxy)-6,7-dimethoxyquinoline 1-oxide
N-[4-[(6,7-Dimethoxy-1-oxido-4-quinolinyl)oxy]phenyl]-N'-(4-fluorophenyl)-1,1-cyclopropanedicarboxamide
1,1-Cyclopropanedicarboxamide, N-[4-[(6,7-dimethoxy-1-oxido-4-quinolinyl)oxy]phenyl]-N'-(4-fluorophenyl)- | [Molecular Formula]
C28H24FN3O6 | [MDL Number]
MFCD34596854 | [MOL File]
1621681-63-7.mol | [Molecular Weight]
517.51 |
| Hazard Information | Back Directory | [Uses]
Cabozantinib N-oxide is a impurity of Cabozantinib (X745500), a medication used to treat medullary thyroid cancer. As well, it can be used in biological study. Computational network biological approach based on pathway cross-talk inhibition identified new synergistic drug combinations using raloxifene and cabozantinib for treatment of human breast cancer in xenograft mouse model. Potent c-MET inhibitor. |
|
|